Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Unisys Corporation (NYSE: UIS), and certain officers. The class action, filed...
-
NEW YORK, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR), and certain officers. The...
-
NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Rivian Automotive, Inc. (“Rivian” or the “Company”) (NASDAQ: RIVN). Such investors are...
-
NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Establishment Labs Holdings Inc. (“Establishment Labs” or the “Company”) (NASDAQ: ESTA)....
-
NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Allstate Corporation (“Allstate” or the “Company”) (NYSE: ALL). Such investors are...
-
NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Olaplex Holdings, Inc. (“Olaplex” or the “Company”) (NASDAQ: OLPX). Such investors are...
-
NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Accelerate Diagnostics, Inc. (“Accelerate” or the “Company”) (NASDAQ: AXDX). Such...
-
NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Seagate Technology Holdings plc (“Seagate” or the “Company”) (NASDAQ: STX). Such investors...
-
NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Pfizer Inc. (“Pfizer” or the “Company”) (NYSE: PFE). Such investors are advised to...
-
NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. (“PTC” or the “Company”) (NASDAQ: PTCT). Such investors are advised...